C57BL/6N-Flgtm1.1Arte Hrnrtm1.1Arte/Ieg

Status

Available to order

EMMA IDEM:05513
Citation informationRRID:IMSR_EM:05513 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameC57BL/6N-Flgtm1.1Arte Hrnrtm1.1Arte/Ieg
Alternative nameFLG KO conv
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolFlgtm1.1Arte, Hrnrtm1.1Arte
Gene/Transgene symbolFlg, Hrnr

Information from provider

Provider Helmholtz Zentrum Muenchen
Provider affiliationInstitute of Experimental Genetics, Helmholtz Zentrum Muenchen German Research Center for Environmental Health (GmbH)
Genetic informationTargeting strategy based on the assumption that the mouse Flg and Hrnr (or Hrnr1) loci on chromosome 3 correspond to the human FLG locus. Two subsequent rounds of gene targeting in the same B6N ES clone have been performed to inactivate the two mouse loci: the first targeting event has replaced exons 1-23 in the Flg locus with a loxP-neomycin cassette and the second targeting event has replaced exons 26-33 in the Hrnr locus with a puromycin cassette-loxP construct. Transient in vitro expression of cre recombinase has resulted in the production of a correctly targeted ES cell clone, with the two constitutive knock-out alleles.
Phenotypic informationTO BE PROVIDED
Breeding historyMaintained on C57BL/6N background.
ReferencesNone available
Homozygous fertilenot known
Homozygous viablenot known
Homozygous matings requirednot known
Immunocompromisednot known

Information from EMMA

Archiving centreHelmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany
Animals used for archivingheterozygous C57BL/6NTac males, wild-type C57BL/6N females
Stage of embryos2-cell

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • decreased circulating serum albumin level / IMPC
MGI phenotypes (gene matching)
  • small ears / MGI
  • thick ears / MGI
  • scaly skin / MGI
  • dermatitis / MGI
  • flaky skin / MGI
  • shiny skin / MGI
  • skin lesions / MGI
  • abnormal epidermal layer morphology / MGI
  • thick epidermis / MGI
  • epidermal desquamation / MGI
  • abnormal epidermis stratum granulosum morphology / MGI
  • abnormal epidermis stratum corneum morphology / MGI
  • hyperkeratosis / MGI
  • decreased body size / MGI
  • abnormal lipid level / MGI
  • abnormal humoral immune response / MGI
  • acanthosis / MGI
  • abnormal skin morphology / MGI
  • postnatal lethality / MGI
  • increased IgG level / MGI
  • increased IgE level / MGI
  • impaired skin barrier function / MGI
  • abnormal hair cuticle / MGI
  • dry skin / MGI
  • increased cholesterol level / MGI
  • skin inflammation / MGI
  • immune system phenotype / MGI
  • abnormal skin physiology / MGI
  • increased susceptibility to type IV hypersensitivity reaction / MGI
  • increased IgG1 level / MGI
  • increased IgG2a level / MGI
  • increased interferon-gamma secretion / MGI
  • increased interleukin-10 secretion / MGI
  • increased interleukin-13 secretion / MGI
  • increased interleukin-17 secretion / MGI
  • increased interleukin-4 secretion / MGI
  • increased interleukin-5 secretion / MGI
  • abnormal cytokine level / MGI
  • increased splenocyte proliferation / MGI
  • thin epidermis stratum granulosum / MGI
  • decreased keratohyalin granule number / MGI
  • orthokeratosis / MGI
  • epidermal spongiosis / MGI
  • abnormal skin appearance / MGI
  • integument phenotype / MGI
  • abnormal tail ring morphology / MGI
  • tail necrosis / MGI
  • short ears / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).